Abbott Laboratories
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
FY2007
Asset Breakdown FY2015
Total Assets: $41.25B
Liabilities Breakdown FY2015
Total Liabilities: $20.04B
Asset Breakdown
Total Assets: $41.25B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $5.00B | 12.1% |
| Accounts Receivable | $3.42B | 8.3% |
| Inventory | $2.60B | 6.3% |
| Property, Plant & Equipment | $5.73B | 13.9% |
| Goodwill | $9.64B | 23.4% |
| Intangible Assets | $5.56B | 13.5% |
| Other Assets | $9.30B | 22.5% |
Liabilities Breakdown
Total Liabilities: $20.04B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.08B | 5.4% |
| Long-Term Debt | $5.87B | 29.3% |
| Other Liabilities | $13.08B | 65.3% |